ロード中...
Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study
BACKGROUND: Secondary prevention of atrial fibrillation (AF) could be carried out by means of antiarrhythmic drugs; however this strategy has not received any endorsement because these drugs are burdened by a high risk of proarrhythmic events (flecainide, sotalol) or extracardiac effects (amiodarone...
保存先:
| 出版年: | Cardiol Res |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elmer Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681845/ https://ncbi.nlm.nih.gov/pubmed/31413779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/cr909 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|